Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vor Biopharma Inc (NQ: VOR ) 0.9700 +0.0100 (+1.04%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 268,688 Open 0.9800 Bid (Size) 0.9600 (1) Ask (Size) 0.9938 (6) Prev. Close 0.9600 Today's Range 0.9700 - 1.010 52wk Range 0.9000 - 3.180 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) July 09, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) June 04, 2024 From Vor Biopharma Via GlobeNewswire Performance YTD -56.50% -56.50% 1 Month -1.95% -1.95% 3 Month -44.25% -44.25% 6 Month -59.75% -59.75% 1 Year -67.88% -67.88% More News Read More VOR Stock Earnings: Vor Biopharma Beats EPS for Q1 2024 May 09, 2024 Via InvestorPlace Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update May 09, 2024 From Vor Biopharma Via GlobeNewswire Vor Biopharma: Q4 Earnings Insights March 20, 2024 Via Benzinga Vor Bio to Participate in Upcoming Investor Conferences May 06, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 03, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors May 02, 2024 From Vor Biopharma Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session April 05, 2024 Via Benzinga Vor Bio to Participate in Upcoming Investor Conferences April 01, 2024 From Vor Biopharma Via GlobeNewswire The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness March 28, 2024 Via InvestorPlace VOR Stock Earnings: Vor Biopharma Beats EPS for Q4 2023 March 20, 2024 Via InvestorPlace Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update March 20, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) March 05, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio to Participate in Upcoming Investor Conferences March 04, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference February 07, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) February 02, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update January 17, 2024 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) December 21, 2023 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) December 01, 2023 From Vor Biopharma Via GlobeNewswire Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit November 27, 2023 From Vor Biopharma Via GlobeNewswire Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference November 09, 2023 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update November 07, 2023 From Vor Biopharma Via GlobeNewswire Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) November 03, 2023 From Vor Biopharma Via GlobeNewswire Vor Bio to Participate in Upcoming Investor Conferences November 03, 2023 From Vor Biopharma Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.